| Name | Title | Contact Details |
|---|
Uroplasty is a global medical company committed to offering transformative treatment options through specialty physicians. Our products are designed to help providers change the lives of their voiding dysfunction patients and strengthen the efficiency of their practices. Uroplasty’s products include the Urgent® PC Neuromodulation System, a non-drug, non-surgical office-based treatment for Overactive Bladder and associated symptoms of urinary urgency, urinary frequency and urge incontinence. Urgent PC is an FDA-cleared system that delivers PTNS (Percutaneous Tibial Nerve Stimulation) and is also indicated for the treatment of fecal incontinence outside the US market. Uroplasty also offers Macroplastique®, an injectable urethral bulking agent for female stress urinary incontinence primarily due to intrinsic sphincter deficiency. Female SUI only in U.S.; male and female SUI outside the U.S. Uroplasty products are typically used when a patient’s treatment goals are not met after conservative and/or drug therapies. Providers and patients alike appreciate that Uroplasty products provide low-risk, effective alternatives to invasive surgery. And because these treatments can be delivered in an office or outpatient setting, the end result is that more patients are given the opportunity to transform their lives with successful treatment.
Aimmune is a clinical-stage biopharmaceutical company advancing a new therapeutic approach, including the development of proprietary product candidates, for the treatment of peanut and other food allergies. Our mission is to improve the lives of people with food allergies by developing and commercializing proprietary desensitization therapies that safely and reliably protect them from accidental exposure to food allergens. We aim to address food allergies by providing a treatment option that goes beyond the current protocols of avoiding exposure to food allergens and carrying epinephrine for administration in case of accidental exposure. Our CODIT™ system is based on extensive independent scientific research demonstrating that most patients with food allergies can become desensitized to the allergens, or proteins, in a particular food through the oral administration of gradually increasing amounts of the allergens. In oral immunotherapy (OIT), a very small amount of an allergen is administered on a daily basis and then regularly increased until desensitization to a certain amount of the allergen has been achieved. We plan to develop and commercialize standardized, pharmaceutical-grade food allergens for our CODIT™ (characterized oral desensitization immunotherapy) system, our system for OIT. Our lead product candidate, AR101, is a standardized, complex mixture of 13 naturally occurring proteins and pharmaceutical-grade ingredients that, with the CODIT system of gradual, controlled updosing and ongoing maintenance dosing, has obtained meaningful desensitization to peanut allergens in our initial clinical studies.
Delta Health Systems is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
Guess & Co. Corporation revitalizes and serves rural communities and neighboring urban communities through technology, real estate, energy, and health care solutions, along with providing diversified solutions to meet the needs of our clients. We work with communities, small businesses, corporations, and governments looking to grow and expand leveraging our solutions. Guess & Co. believes in the power of Rural America and the potential for meaningful partnerships between rural and neighboring urban communities that benefit the United States of America. We are committed to using our resources to build bridges of cooperation and support between rural and neighboring urban communities that strengthen our country. Our objective is to positively impact 100 million lives by 2032 through access, empowerment, economic development, and support through the solutions that we provide to clients. We align ourselves with others who are just as passionate about making lives better through technology, real estate, energy, health care and diversified solutions as we are. From our headquarters in Overland Park, Kansas we deliver solutions to clients in rural and neighboring urban communities. While we are based in the Midwestern region of the United States, our strategic footprint includes over 20 states throughout the country setup to meet the needs of clients. Our core businesses are technology, real estate, energy, and health care solutions. We also serve clients through our diversified solutions which range from consulting to commercial funding.
Wish Recovery is a luxury rehab and detox facility in Los Angeles that offers personalized and comprehensive care for individuals struggling with alcohol and drug addiction.